GE HealthCare key statistics and ratios
In fiscal 2025, GE HealthCare had return on equity of 22.1%, an operating margin of 13.4%, debt equal to 101.3% of equity and a current ratio of 1.37. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|
| Gross margin | 40.8% | 39.1% | 40.5% | 41.7% | 40.0% | 39.9% |
| Operating margin | 15.9% | 13.8% | 12.5% | 13.3% | 13.4% | 13.3% |
| Net margin | 12.8% | 10.4% | 8.0% | 10.1% | 10.1% | 10.0% |
| Free-cash-flow margin | 7.7% | 9.9% | 8.8% | 7.9% | 7.3% | 8.7% |
| Return on equity | 13.5% | 14.7% | 19.0% | 25.6% | 22.1% | 19.6% |
| Return on assets | — | 7.0% | 5.2% | 6.1% | 6.0% | 5.7% |
| Asset turnover | — | 0.67 | 0.65 | 0.60 | 0.59 | 0.57 |
| Current ratio | — | 1.16 | 1.05 | 1.04 | 1.37 | 1.30 |
| Debt to equity | 0.0% | 88.7% | 146.5% | 123.8% | 101.3% | 87.5% |
| Effective tax rate | 20.9% | 22.4% | 31.5% | 20.6% | 22.2% | 20.2% |
| R&D as % of revenue | 4.6% | 5.6% | 6.2% | 6.7% | 6.1% | 6.1% |
| SG&A as % of revenue | 20.3% | 19.8% | 21.9% | 21.7% | 20.5% | 20.5% |
| Capital spending as % of revenue | 1.4% | 1.7% | 2.0% | 2.0% | 2.3% | 2.4% |
| Free cash flow ÷ net income | 60.5% | 95.2% | 109.3% | 78.0% | 72.2% | 87.7% |
| Dividends ÷ net income | 0.0% | 0.0% | 2.6% | 2.8% | 3.1% | 3.0% |
| Dividends and buybacks ÷ free cash flow | 0.0% | 0.0% | 2.4% | 3.5% | 17.5% | 19.3% |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 42.8% | 42.1% | 39.6% | 38.7% | 39.7% | 38.5% | 41.2% | 40.3% |
| Operating margin | 15.1% | 13.2% | 13.1% | 12.7% | 14.5% | 10.0% | 14.0% | 14.6% |
| Net margin | 13.6% | 11.8% | 9.7% | 8.7% | 10.3% | 7.6% | 10.6% | 11.2% |
| Free-cash-flow margin | 15.2% | 2.1% | 0.2% | 9.4% | 16.1% | 2.2% | 1.3% | 14.4% |
| Current ratio | 1.04 | 0.98 | 1.16 | 1.18 | 1.37 | 1.22 | 1.26 | 1.30 |
| Debt to equity | 106.0% | 95.3% | 105.8% | 102.9% | 96.3% | 94.9% | 92.0% | 85.9% |
| R&D as % of revenue | 6.5% | 7.2% | 6.0% | 5.7% | 5.7% | 6.7% | 6.1% | 5.8% |
| SG&A as % of revenue | 21.2% | 21.8% | 20.6% | 20.3% | 19.5% | 21.8% | 21.1% | 20.0% |
Financial health
- Short-term assets cover short-term liabilities $11.5bn of assets due within a year against $8.8bn of liabilities due within a year.
- Short-term assets cover long-term liabilities $11.5bn short-term assets against $17.7bn of longer-dated liabilities.
- More cash than debt $2.8bn of cash against $10.0bn of debt.
- Debt below 40% of shareholders' equity Debt is 86% of equity.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt $2.4bn of operating cash flow against $10.0bn of debt.
- Operating profit covers interest at least five times over Interest not separately reported. Not assessable.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.
Compare with peers
- Boston Scientific statistics
- Koninklijke Philips NV statistics
- Stryker Corporation statistics
- Medtronic statistics
- Baxter International statistics
Head to head: BSX vs GEHCGEHC vs PHGGEHC vs SYKGEHC vs MDT
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies